Capricor Therapeutics, Inc. (CAPR)
9.92
+0.33
(+3.44%)
USD |
NASDAQ |
Aug 31, 16:00
9.875
-0.04
(-0.45%)
After-Hours: 19:43
Capricor Therapeutics Cash and Short Term Investments (Quarterly) : 237.93M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 237.93M |
| March 31, 2026 | 278.61M |
| December 31, 2025 | 318.13M |
| September 30, 2025 | 98.57M |
| June 30, 2025 | 122.80M |
| March 31, 2025 | 144.78M |
| December 31, 2024 | 151.52M |
| September 30, 2024 | 85.03M |
| June 30, 2024 | 29.46M |
| March 31, 2024 | 39.92M |
| December 31, 2023 | 39.49M |
| September 30, 2023 | 28.52M |
| June 30, 2023 | 37.79M |
| March 31, 2023 | 45.17M |
| December 31, 2022 | 41.42M |
| September 30, 2022 | 46.61M |
| June 30, 2022 | 51.42M |
| March 31, 2022 | 58.33M |
| December 31, 2021 | 34.89M |
| September 30, 2021 | 40.84M |
| June 30, 2021 | 38.08M |
| March 31, 2021 | 41.88M |
| December 31, 2020 | 32.67M |
| September 30, 2020 | 35.30M |
| June 30, 2020 | 36.25M |
| Date | Value |
|---|---|
| March 31, 2020 | 13.22M |
| December 31, 2019 | 9.885M |
| September 30, 2019 | 7.060M |
| June 30, 2019 | 6.124M |
| March 31, 2019 | 7.355M |
| December 31, 2018 | 7.542M |
| September 30, 2018 | 10.79M |
| June 30, 2018 | 12.87M |
| March 31, 2018 | 13.78M |
| December 31, 2017 | 14.87M |
| September 30, 2017 | 14.51M |
| June 30, 2017 | 13.09M |
| March 31, 2017 | 12.87M |
| December 31, 2016 | 17.54M |
| September 30, 2016 | 21.12M |
| June 30, 2016 | 11.35M |
| March 31, 2016 | 14.26M |
| December 31, 2015 | 13.57M |
| September 30, 2015 | 17.22M |
| June 30, 2015 | 21.13M |
| March 31, 2015 | 24.47M |
| December 31, 2014 | 11.01M |
| September 30, 2014 | 13.83M |
| June 30, 2014 | 16.29M |
| March 31, 2014 | 13.86M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| REGENXBIO, Inc. | 105.74M |
| Cytokinetics, Inc. | 1.169B |
| Emergent BioSolutions, Inc. | 140.90M |
| Rigel Pharmaceuticals, Inc. | 95.33M |
| United Therapeutics Corp. | 2.662B |